CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top […]
Several Big Surprises in 2018’s Top 10 Lab Stories
Actions by federal government, judges, payers require attention from every lab to stay compliant
- By Robert Michel
- > From the Volume XXV No. 18 - December 24, 2018 Issue
- Tags: acla, american clinical laboratory, Anatomic pathology, cancer screening tests, clinical lab, clinical lab testing, clinical laboratories, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical laboratory test, clinical labs, companion diagnostic, Companion diagnostics, compliance requirements, cpt, CPT® codes, dark report, digital pathology, digital pathology system, dna sequencing, false claims act, federal false claims act, genetic test, genetic testing, genetic testing companies, genetic testing services, genetic tests, histopathology, hospital lab outreach programs, lab business, lab industry, lab outreach, lab test, lab test prices, lab testing, lab testing companies, lab tests, laboratories, laboratory association, laboratory fee schedule, laboratory test, Medicare, Medicare Part B, new diagnostic technologies, outreach lab, pathologists, Pathology group, pathology groups, pathology practice, pharmacogenomic tests, private payer, the dark report, Theranos
